Electronic Fetal Monitoring: Electronic Fetal Monitoring: A Standardized Approach

Monday, July 8, 2024, 12:00 AM - Monday, July 7, 2025, 11:59 PM

Using standardized definitions and interpretation strategies makes constructing a practical approach to fetal heart rate management possible. Additionally, an evidence-based approach that addresses the most significant fetal heart rate characteristics can be feasible for improving neonatal outcomes. During this session, participants will learn to recognize and respond to fetal monitoring data, which will facilitate a clinician’s ability to provide quality patient care.

A recording of the live OBI 2024 Webinar Series lecture, Electronic Fetal Monitoring: Electronic Fetal Monitoring: A Standardized Approach, held on June 26, 2024.

Release Date: July 8, 2024
Expiration Date: July 7, 2025
Approximate Time to Complete:  60 minutes

This recorded training is by invitation only for the members of The Obstetrics Initiative. 
Click on Begin Activity to get started, or see Registration section for more detailed instructions.

1. Discuss strategies for management of labor dystocia and potential for prevention of it.
2. Distinguish between the 3 elements of EFM standardization
3. Evaluate an organized, systematic ABCD approach to FHR management

There is no fee for this module, however, registration is required.  If you don't already have a profile in the CE portal you will need to create one during the registration process.  

Instructions for Completion

1. Click Begin Activity
2. Click Register and complete the process. Click on the activity link at the bottom the confirmation pop-up window to return to the module (a direct link to the module is also provided in the registration confirmation email)
3. Click Launch Video
4. Upon completion of the module, click Attestation and answer the 1 attestation question, click Check Answer, click the green   button in the upper right corner.
5. Complete the CE Evaluation (if you are not automatically directed to the evaluation upon completion of the attestation, go to My CME > Evaluations & Certificates)
   
   

Need Assistance? [email protected]

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Non-Physician (Attendance) (1.00 hours), Nursing CE (ANCC) (1.00 hours)

 

 

In support of improving patient care, this enduring activity has been planned and implemented by Beaumont Health and The Obstetrics Initiative. Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine CME: Beaumont Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing CE: Beaumont Health designates this activity for a maximum of 1.0 ANCC contact hour.  Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Attention PHYSICIAN participants: Credit will be reported to CME Passport within 30 days of completion of the evaluation.  If you do NOT want your credit reported to CME Passport, you must opt out at https://beaumont.cloud-cme.com > Sign In > My CME > Profile.  For more information about CME Passport, visit http://cmepassport.org.

Disclosure of Financial Relationships: The following speakers and/or planning committee members have identified the following relevant financial relationship(s) with ineligible companies. All other individuals involved with this activity have no relevant financial relationships with ineligible companies to disclose:

 Rebecca Cypher, MSN: Continuing Education Hours Provider/Consultant-Clinical Computer Systems

Disclaimer: The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Unapproved Use: It is the policy of Beaumont Health to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this accredited CE activity may reference off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 Additional Resources:

1.  Miller, L.A., Miller, D, Cypher, R.L.  (2021).  Mosby's Pocket Guide to Fetal Monitoring:  A Multidisciplinary Approach (9th ed).  Elsevier.   

2.  Cypher, R. L.  (2023).  Intrapartum fetal surveillance. In S Murray, E McKinney, K Holub, R Jones.  Foundations of Maternal-Newborn and Women’s Health Nursing (8th ed.).  Elsevier.   

3.  Cypher, R. L.  (2018).  A standardized approach to electronic fetal monitoring in critical care obstetrics. Journal of Perinatal & Neonatal Nursing, 32(3), 212-221. 

4.  Raghuraman N. Response to category II tracings: Does anything help? Seminars in Perinatology 2020; 44(2): 151217).   

5.  Reddy UM, Weiner SJ, Saade GR, Varner MW, Blackwell SC, Thorp Jr JM, Tita AT, Miller RS, Peaceman AM, McKenna DS, Chien EK. Intrapartum resuscitation interventions for category II fetal heart rate tracings and improvement to category I. Obstetrics & Gynecology. 2021;138(3):409-16. 

6.  Shields LE, Wiesner S, Klein C, Pelletreau B, Hedriana HL. A standardized approach for category II fetal heart rate with significant decelerations: maternal and neonatal outcomes. American Journal of Perinatology. 2018;35(14):1405-10.

Mitigation of Relevant Financial Relationships

Beaumont Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.